All three patients with rejection episodes showed GGTP elevation, On the first patient who had two rejection episodes, plasma GGTP elevation preceded each. On the second and third patients, GGTP elevation coincided with the onset of rejection.
Of the 14 patients investigated, all but two were found to have raised plasma GGTP levels at some stage during the course of the investigation. On the majority of these, enzyme levels did not exceed twice the upper limit of normal. Three patients had graft rejection episodes. One of these patients had a second episode of rejection. Rejection was generally considered to have occurred when there was a simultaneous fall in urine output, rise in plasma creatinine and blood urea levels and clinical deterioration. Two patients died during the course of the study.
The possible influence of transplant rejection, low urine output, dialysis, azathioprine administration infection and surgery on plasma GGTP levels was considered. The effect of these factors is shown in Tables 1 and 2 and considered below. In the tables a rise in GGTP activity is defined as a change in GGTP levels exceeding 30 i.u./1 persisting for more than 24 h. A change of this magnitude having been found to exceed normal day-to-day variation in serum enzyme activity. Where pre-transplant GGTP levels were not available, transplantation was considered to have resulted in a rise in GGTP if the enzyme was elevated at the initial determination.
Effect of low urine output
Urine output was reduced for at least 48 h to between 500 and 1,000 ml/24 h on eight occasions in four patients. On only two occasions did GGTP elevation result. Urine output was reduced to less than 500 ml in nine patients, and a rise in plasma GGTP levels was observed in five of these. This rise, was, however, coincident with graft rejection in two patients and in the post-transplant period in a third.
MATERIALS AND METHODS
GGTP was determined by a method described in detail elsewhere (Rosalki et al., 1970) using L-yglutamyl-p-nitroanilide as substrate and glycylglycine as glutamyl group acceptor. The upper limit of normal of plasma GGTP activity is 60 i.u./1 at 37°C for males and 50 i.u./1 at 37°C for females.
Fourteen renal transplant patients wereavailable for investigation, and these were followed for some three months following cadaveric renal transplantation. Plasma GGTP levels were determined on specimens obtained six days a week in the month following transplantation, and thereafter bi-weekly or at more frequent intervals depending on the clinical Transplant rejection state. Glutamate-oxaloacetate transaminase, and glutamate-pyruvate transaminase determinations (Reitman and Frankel, 1957) were carried out on many of the samples that showed raised GGTP levels. On some samples GGTP isoenzymes were examined after separation by electrophoresis on cellulose acetate membrane. Isoenzymes were demonstrated by a staining procedure similar to that previously described for leucine aminopeptidase isoenzymes (Meade and Rosalki, 1964) , but substituting y-glutamyl-,B-naphthylamide (2 rng/rnl trisglycylglycine buffer) as substrate, and the azo dye Fast blue B (0.4 mg/ml 10% acetic acid) to detect liberated ,B-naphthylamine.
Urea and creatinine levels were determined on all plasma samples by the Department of Chemical Pathology, using standard AutoAnalyzer methodology. Daily urine output was measured for each patient. The results were charted and considered Effect of dialysis together with the clinical history. Particular attention was paid to therapy.
Recurrent peritoneal dialysis was carried out on Paper read at Southern En&1and and South Wale. Rellional Mcctinll seven patients. None showed a rise in GGTP activity March, 1970. • as a result. When dialysis was discontinued in five 148
The enzyme y-glutamyl transpeptidase (GGTP) catalyses the transfer of the y-glutamyl group from y-glutamyl peptides to other peptides or to L-amino acids. The enzyme is present in normal plasma and raised plasma levels have been reported in hepatic (Szczeklik et al., 1961; Goldbarg et al., 1963) and myocardial disorders (Agostoni et al., 1965; Hedworth-Whitty et al., 1967) . However, of all the body tissues, the kidney shows the highest activity. GGTP was therefore studied in renal transplant patients to determine whether changes in plasma levels might be helpful in the detection of graft rejection episodes. Table 1 . Factors affecting plasma GGrp levelsfollowing renal transplantation. -plasma GGTP levelsunchanged, t rise (greater than 30 Lu./l for a period exceeding 24 h) in plasma GGTP activity, (t ) indicates the presence of more than one factor coinciding.t •indicatesa rise in plasmaGGTPlevel with total activity remaining within the normal range.
All transaminase determinations were made at times of GGTP elevation.
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Haemodialysis was carried out on three patients. In one a rise in GGTP resulted, and was followed by reduced activity when dialysis was discontinued.
Effect of azothioprine
Since the immunosuppressive drug, azothioprine, may be hepatotoxic, its effect on plasmaGGTP levels was investigated. All patients received this drug at some time during the study. Its administration resulted in GGTP elevation in six of the 14 patients, but on all but two of these, elevation coincided with renal surgery or graft rejection.
Effect of infection
Ten episodes of infection were recorded on seven subjects during the course of the study. GGTP elevation resulted from two or three wound infections, two of five urinary infections (coinciding with oliguria in one) and one of two respiratory infections (coinciding with transplantation in one).
Effect of surgical procedures
Renal transplantation was carried out during, or in the week prior to this study on all but two patients. This operation was followed by plasma GGTP elevation in five of the 12 patients.
Exploration of the transplanted kidney was carried out without change in plasma GGTP levels on two patients and one of these underwent removal of the transplanted kidney without change in plasma levels. On a further patient two explorations were carried out each of which resulted in a rise in GGTP activity. Wound exploration was carried out on two patients and on both of these a rise in plasma GGTP level resulted, levels remaining within the normal range in one.
Results of transaminase determinations
Plasma glutarnate-oxaloacetate transaminase (GOT) and glutamate-pyruvate transaminase (GPT) determinations were carried out on five patients with raised GGTP activity in order to detect evidence of possible liver damage. Raised transaminase levels (upper limit of normal for GOT 19 i.u./I at 25°Cand for GPT 17 i.u./I at 25°C) were present in four of these five patients. However, on one patient with elevated GGTP activity, levels were persistently normal and on the second patient, levels returned to normal despite marked increase of GGTP levels.
Isoenzyme studies
Plasma GGTP isoenzyme staining patterns were examined in normal subjects, patients with known liver disease and transplant patients with increased GGTP levels. In addition, kidney homogenates and liver were studied. Kidney tissues showed a single isoenzyme staining band located at the origin, whereas in liver, staining was confined to the anodal side of the origin. Normal sera showed a single faint staining band between the ot2 and ,a-globulins. Patients with liver disease (hepatitis, cirrhosis, obstructive jaundice, or neoplastic involvement of the liver) showed at least two prominent staining bands, one between the ot 1 and ot 2 and the second between the ot 2 and ,a-globulins. The two patients with raised plasma GGTP levels but normal transaminase activity were repeatedly examined to determine whether an isoenzyme with the mobility of the isoenzyme of kidney tissue could be detected in the plasma. However, at no time was the kidney isoenzyme identifiable. In these and in other patients with high GGTP levels the plasma isoenzyme pattern was in no way distinguishable from that found in patients with liver disease.
A comparison of heat stability, urea inhibition and substrate affinities of the GGTP of liver and kidney tissues did not indicate significant differences in the properties of the enzyme from these tissues. Differentiation could only be achieved by electrophoretic or chromatographic separation.
DISCUSSION
In general, elevated plasma GGTP activity indicates a disorder of the hepato-biliary system (Rosalki et al., 1970) . Since, however, the enzyme is present in the kidney at a level of activity at least 10 times greater than that of liver tissue, it is logical to anticipate that renal damage might also result in raised plasma levels.
This study has confirmed that elevated plasma GGTP activity is a usual finding in patients who have undergone renal transplantation, and has indicated those situations in which elevation may commonly be expected. Of those factors which have been considered, raised plasma GGTP activity would appear to be consistently associated with rejection of the transplanted kidney and to be a common accompaniment of renal or wound surgery or infection. Transplantation itself, generally results in elevated activity in the immediate post-operative period. Reduced urinary output, haemo-or peritoneal dialysis, drug administration and chest infections did not appear to generally result in plasma enzyme elevation.
The lack of correlation between elevated plasma activity and urine output would suggest that excretion in the urine is not an important mode of elimination of the plasma enzyme. It is true that the enzyme is normally present in urine, however, the iso-enzyme characteristics of the urinary enzyme differ from that of the enzyme in plasma and the molecular weight of the plasma enzyme is greater than that of molecules normally filtered at the glomerulus (Szewczuk, 1966) . As with other high molecular weight enzymes (Rosalki and Wilkinson, 1959) the appearance of GGTP in normal urine may be the result of 'wear and tear' breakdown of urinary tract cells, rather than excretion of the plasma enzyme.
The role of liver damage as a possible cause of GGTP elevation in these patients requires further consideration. The administration of the hepatotoxic drug azothioprine did not appear to be responsible for GGTP elevation, however, in the post-transplant period, liver damage as a result of nutritional or circulatory disturbances is to be anticipated, and other possible sources of hepatic damage that have to be considered are transfusion hepatitis and opportunistic cytomegalovirus infection. Clinical evidence of hepatitis was lacking and neither of the two patients who came to post mortem showed evidence of liver disorder, although in one of these pulmonary cytomegalovirus infection was widespread. Elevation of plasma GOT and GPT in many of these patients provided supportive evidence of liver damage, but the transaminase enzymes themselves could have originated from damaged renal tissue, for consider-able GOT and GPT activity is found in the kidney (Wroblewski and LaDue, 1956) .
The complete inability to demonstrate an isoenzyme in plasma with the electrophoretic characteristics of the kidney isoenzyme was disappointing, but certainly does not eliminate the kidney as a source of plasma GGTP elevation. Although the liver and kidney isoenzymes showed different electrophoretic mobility, their kinetic characteristics were remarkably similar. In addition, the kinetic characteristics of plasma GGTP in patients with liver disease closely resembled that of liver tissue, although the plasma contained additional GGTP isoenzymes not found in the liver homogenates. It may be, therefore, that the entry of either liver or kidney GGTP into the plasma is accompanied by binding to plasma proteins. In this way, their electrophoretic mobility might be altered and the kidney enzyme rendered indistinguishable from enzyme of hepatic origin. CONCLUSION Although a raised plasma GGTP accompanied each episode of graft rejection, the value of GGTP determination as a procedure for the detection of rejection is diminished by the other factors which may result in its elevation. Nevertheless, in the absence of recent renal or wound surgery or infection or known liver disease, raised plasma GGTP levels are suggestive of transplant rejection and this suggestion is reinforced if transaminase levels are normal.
